ADRX
ADARx Pharmaceuticals, Inc.
14.00$
-1.4%
vs. previous close
Closing price · As of: Nov 16, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2024 | 2025 |
|---|---|---|
| – | 100.0% | |
| – | 2,073.4% | |
| – | 588.6% | |
| – | 2,662.0% | |
| – | -2,562.0% | |
| – | -2,119.1% | |
| – | -2,119.1% | |
| – | -2,494.6% |
Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.